U.S. regulator to review recommendation on Fiat Chrysler’s Jeep complaint against Mahindra
January 23, 2020
U.S. regulator plans enforcement actions against former Wells Fargo executives: source
January 23, 2020

Blues health insurers put up $55 million to take on generic drug makers

A group of Blue Cross Blue Shield insurers is investing $55 million in a venture that aims to offer cheaper prices to their members on generic drugs that currently have little or no competition, the companies said on Thursday.

Powered by WPeMatico